Registrations open for Australia’s premier biotech investment and capital raising event


Thursday, 25 July, 2013

AusBiotech and Beacon Events have joined forces to launch Australia’s premier event for biotech investment and capital raising - Australia Biotech Invest.

To be held from 28-29 October 2013 at the Melbourne Convention Centre, the conference will bring world-leading biotech innovators together with Australia’s investment community to discover and fund the future of biotech.

Featuring a mix of expert keynotes and biotech company presentations, the conference merges market intelligence with investment opportunities and will act as your guide to successful biotech investment.

Australia Biotech Invest features a limited number of company spotlight slots, offering biotech companies the opportunity to showcase their product pipeline and its investment potential to the assembled audience of investors, venture capitalists, financiers and potential JV partners.

Registrations are open for investors wishing to attend and attendance is free for qualified investors. Sponsorship packages are also available now.

See www.ausbiotechinvest.com for more information or contact Hayley Laing at hlaing@ausbiotech.org.

Related News

DDX53 gene linked to autism spectrum disorder

While DDX53, located on the X chromosome, is known to play a role in brain development...

ADHD drug shows promise for treating meth addiction

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be...

Quitting smoking increases life expectancy even for seniors

Although the benefits of quitting smoking diminish with age, there are still substantial gains...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd